Table 1 Patient Characteristics
From: Decreased SATB1 expression promotes AML cell proliferation through NF-κB activation
Variable | SATB1 low (N = 32) | SATB1 high (N = 20) | P value | ||
|---|---|---|---|---|---|
Median (range) | No. | Median (range) | No. | ||
Age, years | 50.5 (19–78) | 51 (16–79) | 0.839 | ||
≤ 55 | 19 | 12 | |||
> 55 | 13 | 8 | |||
Gender | 0.430 | ||||
Male | 18 | 9 | |||
Female | 14 | 11 | |||
WBC (× 109) | 16.82 (0.7–198.34) | 11.32 (0.6–283.8) | 0.549 | ||
RBC (× 1012) | 2.4 (1.33–4.49) | 2.715 (1.25–4.04) | 0.706 | ||
HGB (g/L) | 72 (49–120) | 83.5 (40–129) | 0.600 | ||
PLT (× 109) | 47 (3–97) | 56 (8–104) | 0.624 | ||
Blast (%) | 60 (19.7–100) | 71.25 (22–94) | 0.420 | ||
FAB subtype | |||||
M0 | 1 | 0 | |||
M1 | 2 | 3 | |||
M2 | 9 | 6 | |||
M3 | 6 | 3 | |||
M4 | 5 | 3 | |||
M4Eo | 1 | 0 | |||
M5 | 6 | 4 | |||
Mixed AML | 2 | 1 | |||
CR rate | 57.14% | 76.47% | 0.189 | ||
Missing valuea | 4 | 3 | |||